Search Results
You are looking at 1 - 7 of 7 items for
- Author: Dan Li x
- Refine by access: All content x
Search for other papers by Dan Wang in
Google Scholar
PubMed
Search for other papers by Chu-Dan Liu in
Google Scholar
PubMed
Search for other papers by Meng-Li Tian in
Google Scholar
PubMed
Search for other papers by Cheng-Quan Tan in
Google Scholar
PubMed
Search for other papers by Gang Shu in
Google Scholar
PubMed
Search for other papers by Qing-Yan Jiang in
Google Scholar
PubMed
Search for other papers by Lin Zhang in
Google Scholar
PubMed
Key Laboratory of Agro-Ecological Processes in Subtropical Region, Laboratory of Animal Nutritional Physiology and Metabolic Process, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, Hunan, China
Search for other papers by Yu-Long Yin in
Google Scholar
PubMed
Dietary fibers and their microbial fermentation products short-chain fatty acids promote metabolic benefits, but the underlying mechanisms are still unclear. Recent studies indicate that intestinal lipid handling is under regulatory control and has broad influence on whole body energy homeostasis. Here we reported that dietary inulin and propionate significantly decreased whole body fat mass without affecting food intake in mice fed with chow diet. Meanwhile, triglyceride (TG) content was decreased and lipolysis gene expression, such as adipose triglyceride lipase (A tgl), hormone-sensitive lipase (H sl) and lysosomal acid lipase (L al) was elevated in the jejunum and ileum of inulin- and propionate-treated mice. In vitro studies on Caco-2 cells showed propionate directly induced enterocyte Atgl, Hsl and Lal gene expression and decreased TG content, via activation of phosphorylation of AMP-activated protein kinase (p-AMPK) and lysine-specific demethylase 1 (LSD1). Moreover, inulin and propionate could increase intestinal lipolysis under high-fat diet (HFD)-fed condition which contributed to the prevention of HFD-induced obesity. Our study suggests that dietary fiber inulin and its microbial fermentation product propionate can regulate metabolic homeostasis through regulating intestinal lipid handling, which may provide a novel therapeutic target for both prevention and treatment of obesity.
Search for other papers by Yunshuang Yue in
Google Scholar
PubMed
Search for other papers by Yi Wang in
Google Scholar
PubMed
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Zhigang Song in
Google Scholar
PubMed
Search for other papers by Hongchao Jiao in
Google Scholar
PubMed
Search for other papers by Hai Lin in
Google Scholar
PubMed
Bacterial lipopolysaccharide (LPS), also known as endotoxin, induces profound anorexia. However, the LPS-provoked pro-inflammatory signaling cascades and the neural mechanisms underlying the development of anorexia are not clear. Mammalian target of rapamycin (mTOR) is a key regulator of metabolism, cell growth, and protein synthesis. This study aimed to determine whether the mTOR pathway is involved in LPS-induced anorexia. Effects of LPS on hypothalamic gene/protein expression in mice were measured by RT-PCR or western blotting analysis. To determine whether inhibition of mTOR signaling could attenuate LPS-induced anorexia, we administered an i.c.v. injection of rapamycin, an mTOR inhibitor, on LPS-treated male mice. In this study, we showed that LPS stimulates the mTOR signaling pathway through the enhanced phosphorylation of mTORSer2448 and p70S6KThr389. We also showed that LPS administration increased the phosphorylation of FOXO1Ser256, the p65 subunit of nuclear factor kappa B (P<0.05), and FOXO1/3aThr 24 / 32 (P<0.01). Blocking the mTOR pathway significantly attenuated the LPS-induced anorexia by decreasing the phosphorylation of p70S6KThr389, FOXO1Ser256, and FOXO1/3aThr 24 / 32. These results suggest promising approaches for the prevention and treatment of LPS-induced anorexia.
Search for other papers by Jing Li in
Google Scholar
PubMed
Search for other papers by Pan-Pan Zhao in
Google Scholar
PubMed
Search for other papers by Ting Hao in
Google Scholar
PubMed
Search for other papers by Dan Wang in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Yang-Zi Zhu in
Google Scholar
PubMed
Department of Anesthetic Pharmacology, Xuzhou Medical University, Xuzhou, China
Search for other papers by Yu-Qing Wu in
Google Scholar
PubMed
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
Search for other papers by Cheng-Hua Zhou in
Google Scholar
PubMed
Urotensin II (U-II), a cyclic peptide originally isolated from the caudal neurosecretory system of fishes, can produce proinflammatory effects through its specific G protein-coupled receptor, GPR14. Neuropathic pain, a devastating disease, is related to excessive inflammation in the spinal dorsal horn. However, the relationship between U-II and neuropathic pain has not been reported. This study was designed to investigate the effect of U-II antagonist on neuropathic pain and to understand the associated mechanisms. We reported that U-II and its receptor GPR14 were persistently upregulated and activated in the dorsal horn of L4–6 spinal cord segments after chronic constriction injury (CCI) in rats. Intrathecal injection of SB657510, a specific antagonist against U-II, reversed CCI-induced thermal hyperalgesia and mechanical allodynia. Furthermore, we found that SB657510 reduced the expression of phosphorylated c-Jun N-terminal kinase (p-JNK) and nuclear factor-κB (NF-κB) p65 as well as subsequent secretion of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α). It was also showed that both the JNK inhibitor SP600125 and the NF-κB inhibitor PDTC significantly attenuated thermal hyperalgesia and mechanical allodynia in CCI rats. Our present research showed that U-II receptor antagonist alleviated neuropathic pain possibly through the suppression of the JNK/NF-κB pathway in CCI rats, which will contribute to the better understanding of function of U-II and pathogenesis of neuropathic pain.
Institute of Metabolism and Endocrinology, Department of Clinical Laboratory, Department of Orthopaedics, The Second Xiang-Ya Hospital of Central South University, 410011 ChangSha, People's Republic of China
Search for other papers by Yan-Hong Bu in
Google Scholar
PubMed
Search for other papers by Yu-Ling He in
Google Scholar
PubMed
Search for other papers by Hou-De Zhou in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Dan Peng in
Google Scholar
PubMed
Search for other papers by Ai-Guo Tang in
Google Scholar
PubMed
Search for other papers by Ling-Li Tang in
Google Scholar
PubMed
Search for other papers by Hui Xie in
Google Scholar
PubMed
Search for other papers by Qiu-Xia Huang in
Google Scholar
PubMed
Search for other papers by Xiang-Hang Luo in
Google Scholar
PubMed
Search for other papers by Er-Yuan Liao in
Google Scholar
PubMed
Insulin receptor substrate 1 (IRS1) is an essential molecule for the intracellular signaling of IGF1 and insulin, which are potent anabolic regulators of bone metabolism. Osteoblastic IRS1 is essential for maintaining bone turnover; however, the mechanism underlying this regulation remains unclear. To clarify the role of IRS1 in bone metabolism, we employed RNA interference to inhibit IRS1 gene expression and observed the effects of silencing this gene on the proliferation and differentiation of and the expression of matrix metallopeptidase (MMP) and tumor necrosis factor receptor superfamily, member 11b (TNFRSF11B) in MC3T3-E1 cells. Our results showed that IRS1 short hairpin RNAs can effectively suppress the expression of IRS1, and inhibit the phosphorylation of AKT in IRS1 pathway; reduce the expression of MMP2, MMP3, MMP13, and MMP14, decrease the expression of TNFRSF11B and RANKL (also known as tumor necrosis factor (ligand) superfamily, member 11), however increase the RANKL/TNFRSF11B ratio; decrease cell survival, proliferation, and mineralization, and impair the differentiation of MC3T3-E1 cells. The downregulation of IRS1 had no effect on the expression of MMP1. Our findings suggest that IRS1 not only promotes bone formation and mineralization but also might play roles in bone resorption partly via the regulation of MMPs and RANKL/TNFRSF11B ratio, thus regulates the bone turnover.
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Yan Ji in
Google Scholar
PubMed
Search for other papers by Chunlan Zhao in
Google Scholar
PubMed
Search for other papers by Yapeng Yao in
Google Scholar
PubMed
Search for other papers by Anlan Yang in
Google Scholar
PubMed
Search for other papers by Honghong Jin in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Mingjun San in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Mingjiao Zhang in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Luqing Zhang in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Xuechao Feng in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Yaowu Zheng in
Google Scholar
PubMed
Oxytocin receptor (OXTR) is a G-protein-coupled receptor and known for regulation of maternal and social behaviors. Null mutation (Oxtr−/−) leads to defects in lactation due to impaired milk ejection and maternal nurturing. Overexpression of OXTR has never been studied. To define the functions of OXTR overexpression, a transgenic mouse model that overexpresses mouse Oxtr under β-actin promoter was developed ( ++ Oxtr). ++ Oxtr mice displayed advanced development and maturation of mammary gland, including ductal distention, enhanced secretory differentiation and early milk production at non-pregnancy and early pregnancy. However, ++ Oxtr dams failed to produce adequate amount of milk and led to lethality of newborns due to early involution of mammary gland in lactation. Mammary gland transplantation results indicated the abnormal mammary gland development was mainly from hormonal changes in ++ Oxtr mice but not from OXTR overexpression in mammary gland. Elevated OXTR expression increased prolactin-induced phosphorylation and nuclear localization of STAT5 (p-STAT5), and decreased progesterone level, leading to early milk production in non-pregnant and early pregnant females, whereas low prolactin and STAT5 activation in lactation led to insufficient milk production. Progesterone treatment reversed the OXTR-induced accelerated mammary gland development by inhibition of prolactin/p-STAT5 pathway. Prolactin administration rescued lactation deficiency through STAT5 activation. Progesterone plays a negative role in OXTR-regulated prolactin/p-STAT5 pathways. The study provides evidence that OXTR overexpression induces abnormal mammary gland development through progesterone and prolactin-regulated p-STAT5 pathway.
Transgenic Research Center, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Mingjiao Zhang in
Google Scholar
PubMed
Search for other papers by Salah Adlat in
Google Scholar
PubMed
Search for other papers by Xiaodan Lu in
Google Scholar
PubMed
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Honghong Jin in
Google Scholar
PubMed
Search for other papers by Chenhao Wang in
Google Scholar
PubMed
Search for other papers by Zin Mar Oo in
Google Scholar
PubMed
Search for other papers by Farooq Hayel in
Google Scholar
PubMed
Search for other papers by Quangang Chen in
Google Scholar
PubMed
Search for other papers by Xufeng Han in
Google Scholar
PubMed
Search for other papers by Renjin Chen in
Google Scholar
PubMed
Search for other papers by Xuechao Feng in
Google Scholar
PubMed
Search for other papers by Luqing Zhang in
Google Scholar
PubMed
Search for other papers by Yaowu Zheng in
Google Scholar
PubMed
Obesity is caused by imbalanced energy intake and expenditure. Excessive energy intake and storage in adipose tissues are associated with many diseases. Several studies have demonstrated that vascular growth endothelial factor B (VEGFB) deficiency induces obese phenotypes. However, the roles of VEGFB isoforms VEGFB167 and VEGFB186 in adipose tissue development and function are still not clear. In this study, genetic mouse models of adipose-specific VEGFB167 and VEGFB186 overexpression (aP2-Vegfb167 tg/+ and aP2-Vegfb186 tg/+ ) were generated and their biologic roles were investigated. On regular chow, adipose-specific VEGFB186 is negatively associated with white adipose tissues (WATs) and positively regulates brown adipose tissues (BATs). VEGFB186 upregulates energy metabolism and metabolism-associated genes. In contrast, VEGFB167 has a nominal role in adipose development and function. On high-fat diet, VEGFB186 expression can reverse the phenotypes of VEGFB deletion. VEGFB186 overexpression upregulates BAT-associated genes and downregulates WAT-associated genes. VEGFB186 and VEGFB167 have very distinct roles in the regulation of adipose development and energy metabolism. As a key regulator of adipose tissue development and energy metabolism, VEGFB186 may be a target for obesity prevention and treatment.
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Mingyue Zhao in
Google Scholar
PubMed
Search for other papers by Chenhao Wang in
Google Scholar
PubMed
Search for other papers by Huaizhen Wen in
Google Scholar
PubMed
Search for other papers by Yuntao Zhang in
Google Scholar
PubMed
Search for other papers by Mingxu Lu in
Google Scholar
PubMed
Search for other papers by Salah Adlat in
Google Scholar
PubMed
Search for other papers by Tingting Zheng in
Google Scholar
PubMed
Search for other papers by Mingjiao Zhang in
Google Scholar
PubMed
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Xiaodan Lu in
Google Scholar
PubMed
Search for other papers by Mengwei Guo in
Google Scholar
PubMed
Search for other papers by Hongyu Chen in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, China
Search for other papers by Luqing Zhang in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, China
Search for other papers by Xuechao Feng in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, China
Search for other papers by Yaowu Zheng in
Google Scholar
PubMed
Excessive fat accumulation causes obesity and many diseases. Previous study demonstrates VEGFB universal knockout induces obese phenotypes including expansion of white adipose tissue, whitening of brown adipose tissue, increase of fat accumulation and reduction in energy consumption. However, roles of VEGFB in adipose tissues are not clear. In this study, we have generated a mouse model with adipose-specific VEGFB repression using CRISPR/dCas9 system (Vegfb AdipoDown ) and investigated the roles of VEGFB in adipose development and energy metabolism. VEGFB repression induced significant changes in adipose tissue structure and function. Vegfb AdipoDown mice have larger body sizes, larger volume of white adipose tissues than its wild type littermates. Adipose-specific VEGFB repression induced morphological and functional transformation of adipose tissues toward white adipose for energy storage. Metabolic processes are broadly changed in Vegfb AdipoDown adipose tissues including carbohydrate metabolism, lipid metabolism, nucleotide metabolism and amino acid metabolism. We have demonstrated that adipose VEGFB repression can recapitulate most of the phenotypes of the whole body VEGFB knockout mouse. Intriguingly, approximately 50% VEGFB repression in adipose tissues can almost completely mimic the effects of universal Vegfb deletion, suggesting adipose VEGFB is a major regulator of energy metabolism and may be important in prevention and treatment of obesity.
